Diethylpropion (BioDeep_00000001887)

 

Secondary id: BioDeep_00001867957

human metabolite blood metabolite Chemicals and Drugs Volatile Flavor Compounds


代谢物信息卡片


Investigacion farmaceutica brand OF amfepramone hydrochloride

化学式: C13H19NO (205.14665639999998)
中文名称: 二乙基丙酮, 安非拉酮
谱图信息: 最多检出来源 Homo sapiens(blood) 26.09%

分子结构信息

SMILES: CCN(CC)C(C)C(=O)C1=CC=CC=C1
InChI: InChI=1S/C13H19NO/c1-4-14(5-2)11(3)13(15)12-9-7-6-8-10-12/h6-11H,4-5H2,1-3H3

描述信息

Diethylpropion is only found in individuals that have used or taken this drug. It is a appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)Diethylpropion is an amphetamine that stimulates neurons to release or maintain high levels of a particular group of neurotransmitters known as catecholamines; these include dopamine and norepinephrine. High levels of these catecholamines tend to suppress hunger signals and appetite. Diethylpropion (through catecholamine elevation) may also indirectly affect leptin levels in the brain. It is theorized that diethylpropion can raise levels of leptin which signal satiety. It is also theorized that increased levels of the catecholamines are partially responsible for halting another chemical messenger known as neuropeptide Y. This peptide initiates eating, decreases energy expenditure, and increases fat storage.
A - Alimentary tract and metabolism > A08 - Antiobesity preparations, excl. diet products > A08A - Antiobesity preparations, excl. diet products > A08AA - Centrally acting antiobesity products
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants
C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

同义名列表

60 个代谢物同义名

Investigacion farmaceutica brand OF amfepramone hydrochloride; Marion merrell dow brand OF amfepramone hydrochloride; Marion merrell brand OF amfepramone hydrochloride; Artegodan brand OF amfepramone hydrochloride; Théranol brand OF amfepramone hydrochloride; Temmler brand OF amfepramone hydrochloride; Pro DOC brand OF amfepramone hydrochloride; Vortech brand OF amfepramone hydrochloride; Hoechst brand OF amfepramone hydrochloride; Crinex brand OF amfepramone hydrochloride; Uriach brand OF amfepramone hydrochloride; Nadeau brand OF amfepramone hydrochloride; Medix brand OF amfepramone hydrochloride; Medic brand OF amfepramone hydrochloride; Dexo brand OF amfepramone hydrochloride; 3m Brand OF amfepramone hydrochloride; 2-(diethylamino)-1-phenylpropan-1-one; 2-(Diethylamino)-1-phenyl-1-propanone; 1-Phenyl-2-diethylamino-1-propanone; alpha-Diethylaminopropiophenone; Hydrochloride, diethylpropion; 2-(Diethylamino)propiophenone; Diethylpropion Hydrochloride; 2-Diethylaminopropiophenone; Α-diethylaminopropiophenone; a-Diethylaminopropiophenone; alpha-Benzoyltriethylamine; Α-benzoyltriethylamine; a-Benzoyltriethylamine; (+-)-Diethylpropion; (S)-diethylpropion; Diethylcathinone; Diethylpropione; Diethylpropion; Dietil-retard; Dietil retard; Amfepramonum; DEA no. 1610; Dietilretard; Anfepramona; Amfepramone; Amfepramon; Norex, ifa; Préfamone; Ifa norex; Phepranon; Modératan; Nobesine; Delgamer; Regibon; Maruate; Tenuate; Tepanil; Propion; Regenon; Lipomin; Anorex; Neobes; Diethylpropion; Diethylpropion



数据库引用编号

17 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Ernesto Limón-Bernal, José E Roa-Coria, Ángel Zúñiga-Romero, Juan C Huerta-Cruz, Irma R C Ruíz-Velasco, Francisco J Flores-Murrieta, Eleazar Lara-Padilla, Juan G Reyes-García, Héctor I Rocha-González. Anorectic interaction and safety of 5-hydroxytryptophan/carbidopa plus phentermine or diethylpropion in rat. Behavioural pharmacology. 2021 08; 32(5):368-381. doi: 10.1097/fbp.0000000000000625. [PMID: 33660661]
  • Magdalena Gómez-Silva, Everardo Piñeyro-Garza, Rigoberto Vargas-Zapata, María Elena Gamino-Peña, Armando León-García, Mario Bermúdez de León, Adrián Llerena, Rafael B R León-Cachón. Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial. Scientific reports. 2019 11; 9(1):17833. doi: 10.1038/s41598-019-54436-z. [PMID: 31780765]
  • Jolanta Opacka-Juffry, Thomas Pinnell, Nisha Patel, Melissa Bevan, Meghan Meintel, Colin Davidson. Stimulant mechanisms of cathinones - effects of mephedrone and other cathinones on basal and electrically evoked dopamine efflux in rat accumbens brain slices. Progress in neuro-psychopharmacology & biological psychiatry. 2014 Oct; 54(?):122-30. doi: 10.1016/j.pnpbp.2014.04.009. [PMID: 24795175]
  • Kristiane de Cássia Mariotti, Roselena S Schuh, Priscila Ferranti, Rafael S Ortiz, Daniele Z Souza, Flavio Pechansky, Pedro E Froehlich, Renata P Limberger. Simultaneous analysis of amphetamine-type stimulants in plasma by solid-phase microextraction and gas chromatography-mass spectrometry. Journal of analytical toxicology. 2014 Sep; 38(7):432-7. doi: 10.1093/jat/bku063. [PMID: 25038769]
  • Charles Francisco Ferreira, Juliana Rombaldi Bernardi, Rachel Krolow, Danusa Mar Arcego, Gabriel Rodrigo Fries, Bianca Wollenhaupt de Aguiar, Gabrielle Senter, Flávio Pereira Kapczinski, Patrícia Pelufo Silveira, Carla Dalmaz. Vulnerability to dietary n-3 polyunsaturated fatty acid deficiency after exposure to early stress in rats. Pharmacology, biochemistry, and behavior. 2013 Jun; 107(?):11-9. doi: 10.1016/j.pbb.2013.03.006. [PMID: 23537731]
  • Yang Li, Hong Zhang, Jiangtao Hu, Feng Xue, Yongxin Li, Chengjun Sun. A GC-EI-MS-MS method for simultaneous determination of seven adulterants in slimming functional foods. Journal of chromatographic science. 2012 Nov; 50(10):928-33. doi: 10.1093/chromsci/bms092. [PMID: 22732254]
  • L M De Carvalho, P A Cohen, C V Silva, A P L Moreira, T M Falcão, T R Dal Molin, G Zemolin, M Martini. A new approach to determining pharmacologic adulteration of herbal weight loss products. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment. 2012; 29(11):1661-7. doi: 10.1080/19440049.2012.706834. [PMID: 22849359]
  • Abel Santamaría, Hugo R Arias. Neurochemical and behavioral effects elicited by bupropion and diethylpropion in rats. Behavioural brain research. 2010 Jul; 211(1):132-9. doi: 10.1016/j.bbr.2010.03.023. [PMID: 20307582]
  • Armineh Zohrabian. Clinical and economic considerations of antiobesity treatment: a review of orlistat. ClinicoEconomics and outcomes research : CEOR. 2010; 2(?):63-74. doi: 10.2147/ceor.s5101. [PMID: 21935315]
  • Brian J Cowles. Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient considerations and the role of lisdexamfetamine. Therapeutics and clinical risk management. 2009; 5(?):943-8. doi: 10.2147/tcrm.s6733. [PMID: 20057893]
  • Mark Waterlow, Paul Chrisp. Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome. Core evidence. 2008 Feb; 2(3):173-87. doi: ". [PMID: 21221184]
  • Philippe Unger, Joëlle Nortier, Marie-Carmen Muniz Martinez, Danièle Plein, Jean-Luc Vandenbossche, Pierre Vereerstraeten, Jean-Louis Vanherweghem. High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2003 May; 18(5):906-10. doi: 10.1093/ndt/gfg083. [PMID: 12686663]
  • Sonia Galvan-Arzate, Abel Santamaria. Neurotoxicity of diethylpropion: neurochemical and behavioral findings in rats. Annals of the New York Academy of Sciences. 2002 Jun; 965(?):214-24. doi: . [PMID: 12105097]
  • Marie-Carmen Muniz Martinez, Joëlle Nortier, Pierre Vereerstraeten, Jean-Louis Vanherweghem. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2002 Mar; 17(3):408-12. doi: 10.1093/ndt/17.3.408. [PMID: 11865085]
  • F L Greenway. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2001 Aug; 2(3):199-211. doi: 10.1046/j.1467-789x.2001.00038.x. [PMID: 12120105]
  • H Yu, R B Rothman, C M Dersch, J S Partilla, K C Rice. Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters. Bioorganic & medicinal chemistry. 2000 Dec; 8(12):2689-92. doi: 10.1016/s0968-0896(00)00210-8. [PMID: 11131159]
  • B Mey, H Paulus, E Lamparter, G Blaschke. Kinetics of racemization of (+)- and (-)-diethylpropion: studies in aqueous solution, with and without the addition of cyclodextrins, in organic solvents and in human plasma. Chirality. 1998; 10(4):307-15. doi: 10.1002/(sici)1520-636x(1998)10:4<307::aid-chir4>3.0.co;2-4. [PMID: 9614689]
  • M Pokrajac, B Miljković, B Misailović. Mass spectrometric investigation of 2-aminopropiophenones and some of their metabolites. Rapid communications in mass spectrometry : RCM. 1991 Feb; 5(2):59-61. doi: 10.1002/rcm.1290050202. [PMID: 1804406]
  • M Popa, A M Stefănescu, L Dumitriu. Decrease of urinary levels of adrenergic metabolites including conjugated MHPG after a short term course of diethylpropion in obese children fed a mixed, low-calorie diet. Endocrinologie. 1987 Jul; 25(3):179-86. doi: . [PMID: 3685848]
  • C M Dangor, A H Beckett, A M Veltman. Bioavailability of amfepramone hydrochloride sustained release pellets formulation in healthy subjects. Arzneimittel-Forschung. 1987 Jun; 37(6):736-9. doi: NULL. [PMID: 3663274]
  • A H Beckett, M Stanojcić. Re-evaluation of the metabolism and excretion of diethylpropion in non-sustained and sustained release formulations. The Journal of pharmacy and pharmacology. 1987 Jun; 39(6):409-15. doi: 10.1111/j.2042-7158.1987.tb03411.x. [PMID: 2886596]
  • C M Dangor, A H Beckett, A M Veltman. Simultaneous determination of amfepramon and its two major metabolites in biological fluids by gas liquid chromatography. Arzneimittel-Forschung. 1986 Sep; 36(9):1307-10. doi: NULL. [PMID: 3790180]
  • S L Markantonis, A Kyroudis, A H Beckett. Evaluation of the percutaneous absorption and metabolism of some aminopropiophenones. The Journal of pharmacy and pharmacology. 1986 Jul; 38(7):515-9. doi: 10.1111/j.2042-7158.1986.tb04626.x. [PMID: 2875152]
  • G I Shevelev, Iu I Kardakov. [Dynamics of lipid metabolism in the combined treatment of alimentary obesity]. Terapevticheskii arkhiv. 1984; 56(9):114-6. doi: . [PMID: 6515536]
  • J R Arch. The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice. The American journal of clinical nutrition. 1981 Dec; 34(12):2763-9. doi: 10.1093/ajcn/34.12.2763. [PMID: 7315777]
  • A C Sullivan, W Dairman, J Triscari. (--)-threo-Chlorocitric acid: a novel anorectic agent. Pharmacology, biochemistry, and behavior. 1981 Aug; 15(2):303-10. doi: 10.1016/0091-3057(81)90192-1. [PMID: 7312900]
  • K H Stokholm, G F Jensen, B B Hansen, F Quaade. Very-low-calorie diet in the treatment of massive obesity: preliminary experience. International journal of obesity. 1980; 4(3):213-20. doi: ". [PMID: 7419339]
  • E Abraham. Sacral agenesis with associated anomalies (caudal regression syndrome): autopsy case report. Clinical orthopaedics and related research. 1979 Nov; ?(145):168-71. doi: NULL. [PMID: 535268]
  • H K Hundt, E C Clark, F O Müller. GLC determination of phendimetrazine in serum. Journal of pharmaceutical sciences. 1975 Jun; 64(6):1041-3. doi: 10.1002/jps.2600640638. [PMID: 1173373]
  • G J Wright, J F Lang, R E Lemieux, M J Goodfriend. The objective and timing of drug disposition studies, appendix III. Diethylpropion and its metabolites in the blood plasma of the human after subcutaneous and oral administration. Drug metabolism reviews. 1975; 4(2):267-76. doi: 10.3109/03602537508993760. [PMID: 1222683]
  • D Mihailova, A Rosen, B Testa, A H Beckett. A pharmacokinetic investigation of the distribution and elimination of diethylpropion and its metabolites in man. The Journal of pharmacy and pharmacology. 1974 Sep; 26(9):711-21. doi: 10.1111/j.2042-7158.1974.tb09355.x. [PMID: 4155748]
  • J F Bridgman, J M Buckler. Letter: Drug-induced gynaecomastia. British medical journal. 1974 Aug; 3(5929):520-1. doi: 10.1136/bmj.3.5929.520-b. [PMID: 4414195]
  • B Testa, A H Beckett. The metabolism of diethylpropion in man; influence of changes in drug formulation and urinary pH. Pharmaceutica acta Helvetiae. 1974 Jan; 49(1):21-7. doi: NULL. [PMID: 4854957]
  • B Testa. Some chemical and stereochemical aspects of diethylpropion metabolism in man. Acta pharmaceutica Suecica. 1973 Dec; 10(6):441-54. doi: NULL. [PMID: 4773113]
  • B Testa, A H Beckett. Metabolism and excretion of diethylpropion in man under acidic urine conditions. The Journal of pharmacy and pharmacology. 1973 Feb; 25(2):119-24. doi: 10.1111/j.2042-7158.1973.tb10604.x. [PMID: 4146542]
  • F Banci, G P Cartoni, A Cavalli, A Monai. Effect of sustained-release on the excretion of some metabolites of diethylopropion. Arzneimittel-Forschung. 1972 Oct; 22(10):1724-6. doi: NULL. [PMID: 4677065]
  • B Testa, A H Beckett. Studies on the metabolism of diethylpropion. I. Analytical procedure. Journal of chromatography. 1972 Aug; 71(1):39-54. doi: 10.1016/s0021-9673(01)85688-0. [PMID: 5056248]
  • P M Mace, A D Malcolm, K P Outar, G L Pawan. Comparative effects of four antiobesity agents on blood plasma lipids in man. The Proceedings of the Nutrition Society. 1972 May; 31(1):14A-15A. doi: NULL. [PMID: 5048465]
  • F Banci, G P Cartoni, A Cavalli, A Monai. Excretion of some basic metabolites of diethylpropion in man and rabbit. Arzneimittel-Forschung. 1971 Oct; 21(10):1616-8. doi: NULL. [PMID: 5171897]
  • E C Schreiber. The metabolic alteration of drugs. Annual review of pharmacology. 1970; 10(?):77-98. doi: 10.1146/annurev.pa.10.040170.000453. [PMID: 4392814]
  • S L Tompsett. The detection of basic and other drugs in urine bdistillation and UV spectrophotometry. Clinical chemistry. 1969 Jul; 15(7):591-9. doi: 10.1093/clinchem/15.7.591. [PMID: 5794152]
  • J C De Groot. A survey of the usage of amphetamines in parts of the Sidney community. The Medical journal of Australia. 1968 May; 1(19):826. doi: 10.5694/j.1326-5377.1968.tb28934.x. [PMID: 5656962]
  • E C Schreiber, B H Min, A V Zeiger, J F Lang. Metabolism of diethylpropion-1-C14 hydrochloride by the human. The Journal of pharmacology and experimental therapeutics. 1968 Feb; 159(2):372-8. doi: NULL. [PMID: 4295618]
  • A H Beckett, G T Tucker, A C Moffat. Routine detection and identification in urine of stimulants and other drugs, some of which may be used to modify performance in sport. The Journal of pharmacy and pharmacology. 1967 May; 19(5):273-94. doi: 10.1111/j.2042-7158.1967.tb08089.x. [PMID: 4382400]
  • L Cucurachi, A Strata, U Zuliani, S Castello, P Cucurachi. [Lipid-mobilizing action of some anorexic drugs]. Bollettino della Societa italiana di biologia sperimentale. 1965 Dec; 41(24):1477-8. doi: ". [PMID: 5878157]
  • H Eberhardt, M Debackere. [Demonstration of centrally stimulating substances in pure form and after passage through the body by thin-layer chromatography]. Arzneimittel-Forschung. 1965 Aug; 15(8):929-30. doi: NULL. [PMID: 5898652]
  • G KAMM. [STUDIES ON AN ALMOST SPECIFIC TEST FOR REGENON, REGENON A AND PRELUDIN IN THE URINE]. Beitrage zur gerichtlichen Medizin. 1965; 23(?):119-24. doi: NULL. [PMID: 14346685]